中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2016
Turn off MathJax
Article Contents

Association of programmed cell death-1 gene polymorphisms with chronic hepatitis C virus infection and antiviral effect

DOI: 10.3969/j.issn.1001-5256.2016.09.017
Research funding:

 

  • Published Date: 2016-09-20
  • Objective To investigate the association of single nucleotide polymorphisms( SNPs) of programmed cell death- 1( PD- 1)gene with chronic hepatitis C virus( HCV) infection and the effect of antiviral therapy with interferon combined with ribavirin. Methods A total of 228 patients with chronic hepatitis C( CHC) who were hospitalized in seven hospitals in Hebei Province,China from October 2010 to October 2012 were enrolled and treated with interferon combined with ribavirin as the individualized antiviral therapy. Eighty- one persons who underwent physical examination were enrolled as control group. The Taq Man probe method was used to detect PD- 1 gene polymorphisms. The distribution of alleles and genotypes at PD- 1. 1 and PD- 1. 3 were compared between the two groups,and the association between the SNPs of PD- 1. 1 and PD- 1. 3 and anti- HCV effect was analyzed. The chi- square test was used for the comparison of categorical data between groups. Results The CHC group showed significantly higher frequencies of T allele and TT genotype at PD- 1. 1 than the control group( 52. 41% vs 43. 21%,χ2= 4. 059,P = 0. 044; 28. 51% vs 14. 81%,χ2= 6. 469,P = 0. 039). The SNPs of PD- 1. 1 gene were not significantly associated with complete early virologic response or sustained virologic response( both P > 0. 05). Both groups had CC genotype at PD- 1. 3. Conclusion PD- 1. 1 T allele might be associated with chronic HCV infection,and patients carrying TT genotype have a high risk of chronic HCV infection. PD- 1. 1 polymorphism is not associated with virologic response to anti- HCV therapy.

     

  • loading
  • [1]LAVANCHY D.The global burden of hepatitis C[J].Liver Int,2009,29(Suppl 1):74-81.
    [2]FAWZY MM,WAHID A,NAZMY MH,et al.Association of interleukin-27 rs 153109 single nucleotide polymorphism with spontaneous resolution of hepatitis C virus-genotype 4a infection in egyptian patients[J].Asian Pac J Cancer Prev,2016,17(4):2093-2097.
    [3]YANG Y,LIU H.Association between interleukin-18 gene promoter(-607C/A and-137G/C)polymorphisms and chronic hepatitis C virus infections:a meta-analysis[J].Meta Gene,2015,5:21-31.
    [4]NADIA K,HICHAM E,REDA TM,et al.The complete title:The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C[J].Gene,2015,568(1):31-34.
    [5]KAWAOKA T,HAYES CN,OHISHI W,et al.Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b[J].J Hepatol,2011,54(3):408-414.
    [6]LIU C,JIANG J,GAO L,et al.A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China[J].Int J Genomics,2014,2014:247637.
    [7]MAHMOUDI M,REZAIEMANESH A,SALMANINEJAD A,et al.PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus[J].Autoimmunity,2015,48(7):488-493.
    [8]ZHANG G,LI N,ZHANG P,et al.PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated regionpolymorphism in patients with chronic HBV infection[J].Immunol Lett,2014,162(1 Pt A):212-216.
    [9]SU SS,HE H,KONG LB,et al.Regulatory phenotype,PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy:a randomized clinical trial[J].PLo S One,2014,9(4):e93620.
    [10]URBANI S,AMADEI B,TILA D,et al.Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection:effect of viremia levels and antiviral treatment[J].J Hepatol,2008,48(4):548-558.
    [11]NAKAMOTO N,KAPLAN DE,COLECLOUGH J,et al.Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization[J].Gastroenterology,2008,134(7):1927-1937.
    [12]XIAO W,JIANG LF,DENG XZ,et al.PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection[J].Immunol Res,2016,64(2):412-423.
    [13]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol,2015,31(12):1961-1979.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979.
    [14]ZHANG DD,YE PY,HUANG YX,et al.Analysis of predictive factors for rapid virologic response in treating patients with chronic hepatitis C[J].J Clin Hepatol,2014,30(12):1310-1314.(in Chinese)张丹丹,叶佩燕,黄玉仙,等.慢性丙型肝炎患者获得快速病毒学应答的预测因素分析[J].临床肝胆病杂志,2014,30(12):1310-1314.
    [15]VIDAL-CASTINEIRA JR,LOPEZ-VAZQUEZ A,ALONSOARIAS R,et al.A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping[J].J Hepatol,2012,56(6):1230-1238.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2112) PDF downloads(452) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return